Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{172572,
        author = {Pommala Nagaveni and Racham Reddy Supriya and kasimedu saravanakumar and Devireddy Harshitha and Gajula Vinuthna Grace and Ulava Mahendra Chowdary},
        title = {THERAPEUTIC INSIGHTS INTO PHENOXYBENZAMINE INJECTIONS},
        journal = {International Journal of Innovative Research in Technology},
        year = {2025},
        volume = {11},
        number = {9},
        pages = {187-189},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=172572},
        abstract = {One ligand that can permanently alkylate the alpha-1 adrenergic receptor is phenoxybenzamine. The current study will describe how to formulate and assess an injectable phenoxybenzamine dosage form. [1] The medication we require must be most practical and in the right form before it can reach the intended location of action. Given that injections contain a wide range of medicinal substances. These injections are intended to be administered parenterally.[2] Parenteral injections are known to have the benefits of quick onset of action and instant systemic drug availability. It is crucial to let the doctor know about any known allergies or hypersensitivities before beginning this medicine. Patients with peptic ulcer disease should not use it since it may make their peptic ulcers or other gastrointestinal disorders worse. Due to the paucity of research, it is generally not advised for usage in youngsters.[3] An isotonic aqueous solution, with a PH of 7.4, is the most straight forward and convenient form of an injectable substance.[4]},
        keywords = {Hypersensitivity, Pheochromocytoma, phenoxybenzamine, Myocardial infraction, Hypovolemia},
        month = {February},
        }